Shader Alton reported grant involving 203,634 shares of Sotera Health Co at $0.00 for $0 on May 26, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Executive Officer
Chief Executive Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
203,634Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
579,573Direct
Trade date
May 26, 2026Grant
Filed
May 27, 2026, 5:54 PM ET1-day reporting delay
Accession
0001193125-26-242277Code A · Transaction 88463
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 26, 2026Grant101,817$0.00$0Trade 88464
May 26, 2026Grant375,939$0.00$0Trade 88462
3 transaction rows in this filing. Joint filers share the same rows.

SHC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SHC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.3%1w ago −2%1d ago +0.8%
Returns since7d −1.7%30d +12%90d +24%180d1y

Footnotes in full

F1: These securities consist of RSUs that were granted on May 26, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually over three years in equal increments, commencing March 2, 2027. F2: These securities consist of RSUs that were granted on May 26, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually over three years in equal increments, commencing March 2, 2027. F3: These securities consist of a maximum number of performance-based share appreciation units ("SAUs") that were granted on May 26, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock subject to stock-price-related performance conditions. The SAUs generally vest annually over three years in equal installments, commencing March 2, 2027, subject to performance.